Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 4 × Acromegaly × lanreotide × Clear all

Phase

Phase 4 2 Phase 3 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 2 Acromegaly 2 Pituitary Neoplasms 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neoplasms 1 Gigantism 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

lanreotide 2 Octreotide 2 Cabergoline 2 pegvisomant 1 pasireotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated

4 enrolled 5 charts

Acromegaly, Gigantism, Pituitary Neoplasms

NCT00627796 2008-03-03

ATG1line

Federico II University

Phase 4 Completed

Acromegaly, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡